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SUMMARY
Experimental schistosome infections induce strong parasite-
specific Th2 responses. This study aims to relate human sys-
temic cytokine and antibody levels to schistosome infection
levels and history. Levels of anti-Schistosoma haematobium
antibodies (directed against crude cercariae, egg and adult
worm antigens) and plasma cytokines (IFN-c, IL-2, IL-4,
IL-5, IL-10, IL-13, IL-17, IL-21, and IL-23) were mea-
sured by ELISA in 227 Zimbabweans (6–60 years old) in a
schistosome-endemic area and related to age and infection
status. Egg-positive people had significantly higher levels of
specific antibodies, IL-2, IFN-c and IL-23. In contrast, egg-
negative individuals had significantly higher circulating
IL-10, IL-4, IL-13 and IL-21 that were detected with high
frequency in all participants. Subjects with detectable
plasma IL-17 produced few or no eggs. When analyzed by
age, IL-4 and IL-10 increased significantly, as did schisto-
some-specific antibodies. However, when age was combined
with infection status, IL-5 declined over time in egg-positive
people, while increased with age in the egg-negative group.
Older, lifelong residents had significantly higher IL-4 and
IL-5 levels than younger egg-negative people. Thus, a mixed
Th1 ⁄Th2 systemic environment occurs in people with patent
schistosome infection, while a stronger Th2-dominated suite
of cytokines is evident in egg-negative individuals.
Keywords antibody, Helminth, human, schistosomiasis, sys-
temic cytokine
INTRODUCTION
Schistosomes, commonly known as blood flukes are
important trematode parasites of vertebrates and cause
significant morbidity in humans. Of the three major
human schistosome species, Schistosoma mansoni and
S. japonicum adult parasites inhabit blood vessels of the
intestine causing intestinal schistosomiasis, while S. hae-
matobium adults are located in the bladder and pelvic
plexuses causing urinary schistosomiasis. S. haematobium
is the most prevalent species in sub-Saharan Africa, where
it is responsible for a substantial amount of schistosome-
associated pathology (1). Schistosome-specific acquired
immunity capable of reducing levels of infection or
re-infection develops slowly (2). The nature of these pro-
tective immune responses has been subject to intense anal-
ysis (3–6). Previous studies suggesting that anti-helminth
immune responses fall into a Th1 (pro-inflammatory) and
Th2 (anti-inflammatory) dichotomy with resistance to
infection being associated with Th2 responses (7,8) failed
to fully explain resistance ⁄ susceptibility to infection ⁄
re-infection in people resident in helminth endemic areas.
For example, both Th1 and Th2 responsiveness appear
compromised in schistosomiasis patients, and within the
Th2 compartment, IL-5 responses are suppressed while
IL-4 production is relatively intact (9). Further studies in
Zimbabwe and Egypt showed no clear pattern between
either Th1 or Th2 cytokine responses and infection inten-
sity (10–12). More recently, studies characterising cellular
responses have suggested the existence of a regulatory sub-
set of T cells (Treg), which modulate the effects of Th1
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and Th2 responses through the immunosuppressive cyto-
kines interleukin-10 (IL-10) and transforming growth fac-
tor beta (TGF-b) (13) and have suggested that it is the
balance between Th1, Th2 and Treg responses, which
determines the outcome of helminth infections [reviewed
in (14)].
The cytokine environment created during the develop-
ment of helminth-specific immune responses is thought to
have effects on unrelated antigens by promoting regulatory
effector responses (15,16). Systemic cytokines are promis-
cuous rather than antigen specific in their effects (17).
Thus, cytokines stimulated by helminth antigens can mod-
ify the environment in which responses to other pathogens
occur as illustrated by the systemic effects of gut-restricted
helminths (18,19). Currently, this paradigm is thought to
explain the observed negative associations between hel-
minth infections and atopic ⁄ autoimmune diseases
(15,16,20,21).
Most previous cytokine studies in human schistosomia-
sis have focused either on parasite-specific recall responses
or on a limited range of plasma cytokines (9,22). This
study aims to investigate a comprehensive range of circu-
latory cytokine and antibodies and determine how these
relate to the individual’s current infection levels as well
as to their history of exposure to schistosome infection.
The cytokines measured were the pro-inflammatory
cytokines IFN-c, IL-17, IL-23 and the Th2-associated
cytokines IL-4, IL-5, IL-10, IL-13 and IL-21 as well
as IL-2.
MATERIALS AND METHODS
Study subjects
The study was conducted in two villages, Mutoko and
Rusike in the Mashonaland East Province of Zimbabwe
(3130¢E; 1745¢S), where S. haematobium is endemic. The
participants have been involved in an ongoing study of the
immunoepidemiology of human schistosomiasis (23,24).
Ethical and institutional approval for the study was
obtained from the Medical Research Council of Zimbabwe
and the University of Zimbabwe, respectively. Permission
to conduct the work in this province was obtained from
the Provincial Medical Director. Prior to the study,
informed consent was obtained from all participants or
their guardians ⁄parents in case of children. The villages
were selected because the area has little or no other helm-
inths and a low S. mansoni prevalence (<5%), and there
had been no helminth control programmes in the area.
Therefore, participants had not received any previous anti-
helminthic treatment meaning that the natural immune
responses could be studied in the absence of drug-altered
schistosome responses (25). The main activity in these vil-
lages is subsistence farming; human water contact in rivers
is frequent (at least 4 contacts ⁄person ⁄week) because of
insufficient safe water sources and toilets.
Parasitology and immunology samples
Stool and urine specimens were collected from each partic-
ipant on 3 consecutive days and assayed for S. haematobi-
um, S. mansoni and geo-helminths using standard
procedures (26,27). S. mansoni and geo-helminth infections
were detected from at least 4 Kato-Katz slides (maximum
6), 2 from each of the 2–3 stool samples collected and in
addition, the formal ether concentration method was used
as previously detailed (28,29) on 100 random samples to
confirm the Kato-Katz results. Ten millilitres of venous
blood was collected and processed as previously described
(4) to obtain plasma for cytokine and antibody assays.
Plasma was stored at )20C and freighted frozen to Edin-
burgh where they were thawed for the first time for the
assays described here. A thick smear slide was prepared
upon blood collection for the microscopic detection of
Plasmodium parasites. The inclusion criteria were that a
participant had to (1) have provided at least two urine and
two stool samples over 3 consecutive days, (2) be negative
for intestinal helminths including S. mansoni (no one was
excluded on this criteria as everyone was negative for these
infections), (3) have given at least 10 mL of blood
for serological assays and detection of Plasmodium para-
sites, (4) be lifelong residents of the area (assessed by
questionnaire). Two hundred and twenty-seven people
(112 men and 115 women) aged 6–60 met these criteria
and formed our study population. All participants were
offered anti-helminth treatment as a single treatment with
praziquantel at the recommended dose of 40 mg ⁄kg after
surveying. Malaria cases were treated according to the
treatment regime prescribed by the Ministry of Health in
Zimbabwe.
Antibody and cytokine assays
Circulating levels of IgA, IgE, IgG1, IgG2, IgG3, IgG4
and IgM directed against the three S. haematobium anti-
gens cercariae (CAP), egg (SEA) and SWAP (adult worm)
were detected by indirect enzyme-linked immunosorbent
assays (ELISA) as previously described (30). Cytokine
assays were conducted using capture ELISA with antibody
sets and standards from BD Biosciences (IFN-c, IL-2,
IL-4, IL-5, IL-10, IL-13, IL-21, IL-23) and R and D
Systems (IL-17) following previously published protocols
(31) and manufacturer’s guidelines. All assays were con-
ducted in duplicate ⁄ sample with appropriate negative and
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positive controls for the antibody ELISA. People with
cytokine levels above 0 ng ⁄mL (after the subtraction of
the blank control) were denoted positive for the cytokine
and those with antibody levels above 3 standard deviations
of the negative controls were denoted positive for the anti-
body.
Statistical analyses
The number of people with detectable antibody ⁄ cytokine
levels was compared between schistosome egg-negative
and egg-positive people using a chi-squared test. Explor-
atory plots showed that the relationships between the dif-
ferent cytokines were nonlinear and directional (positive ⁄
negative), so correlation analyses were conducted using
a one-tailed nonparametric Spearman correlation proce-
dure (32).
The changes in cytokine levels with host age were
analysed using a multivariate analysis with cytokine levels
(square root transformed) as dependent variables and sex
(categorical), village of residence (categorical) and host
age (categorical) were the independent variables. Age was
categorised into three groups; 5–10 years, 11–12 years
and 13 years and above reflecting the epidemiological
groupings (previously used for this population (4)) where
schistosome infection levels are rising, peaking and
declining, as well as to give comparable sample sizes for
statistical analyses. The analysis used sequential sums of
squares to allow for the effects of sex and village.
To determine the relationship between all the immunol-
ogy measures and infection status, the 30 variables (9 cyto-
kines + 21 antibody responses) were reduced into
uncorrelated variables by a principal components analysis
(PCA) procedure, a standard technique for reducing
multivariate data to its main independent features by
transforming several correlated variables into fewer uncor-
related variables called principal components (32). The
components are extracted according to the amount of var-
iation in the data they explain, so the first component
explains the most variation, and each subsequent compo-
nent is included if it explains a significant amount of vari-
ation present within the data (32). Principal components
with eigenvalues greater than one were extracted by regres-
sion analysis, and an extracted component was considered
reliable if it had two or more of the original variables with
factor loadings ‡5 or £)5 and below. The relationship
between infection status and the immunology variables
(represented by the principal components) was tested
using a generalised linear model procedure with the
independent variables being sex (male, female), age group,
residential areas (village 1 or 2) and principal components
(continuous variables). Schistosome infection status denoted
as negative for people with zero egg counts for all urine
samples presented or positive for people with at least one
egg detected in one of their urine samples was the depen-
dent variable. All statistical analyses were performed using
the SPSS software.
RESULTS
Infection epidemiology
Overall, S. haematobium infection prevalence in the study
population was 56% with a mean infection intensity of
34 eggs ⁄ 10mL of urine (SEM = 6 eggs ⁄ 10 mL urine, range
0–676 eggs ⁄ 10 mL urine). Although these infection levels
are moderate relative to reports from other areas in Zim-
babwe (30), the World Health Organisation (WHO)
denotes this prevalence level as high; infection intensity is
also classified as high by the WHO definition of having
more than 10% of the population with >50 eggs ⁄ 10 mL of
urine (45 of the 227 participants had >50 eggs per 10 mL
urine) (33). Infection intensity rose to peak in childhood
(11–12 years) followed by a sharp decline in infection
intensity, while prevalence fell more gradually as shown in
Figure 1. There is a low prevalence of nematode infections
in rural Zimbabwe and consistent with a recent study (29),
the prevalence of hookworm, Ascaris lumbicoides and
Trichuris trichiura was zero in our study area. Plasmodium
falciparum is the predominant species of malaria in Zim-
babwe, and our study area is a mesoendemic area for
malaria as detailed in (34) with a prevalence of 11% in
our study population.
Figure 1 Age-associated S. haematobium infection intensity and
prevalence. The intensity of infection was determined by arithme-
tic means of eggs ⁄ 10 mL of urine in each of the 5 age groups.
Bar graph represents infection intensity with standard error of the
mean bars and line graph represents prevalence. Infection inten-
sity followed a convex age-intensity pattern with participant age,
while infection prevalence remained high after peaking in 11- to
12-year-old age group.
T. Milner et al. Parasite Immunology
712  2010 Blackwell Publishing Ltd, Parasite Immunology, 32, 710–721
Frequency of people with detectable antibody and plasma
cytokine levels
All participants produced IgM antibodies directed against
all the three schistosome life stages with the least preva-
lent antibody response being IgE (Table 1), indicating
that they have all been exposed to schistosome antigens.
When partitioned by infection status, a higher proportion
of egg-positive people produced parasite-specific antibod-
ies than egg-negative people (Table 1). This was signifi-
cant for anti-cercariae IgE (P = 0Æ032, c2 = 4Æ233, df = 1)
and IgG4 (P = 0Æ012, c2 = 6Æ1, df = 1), anti-worm
IgG1 (P = 0Æ004, c2 = 8Æ12, df = 1) and IgG3 (P =
0Æ009, c2 = 6Æ44, df = 1) and anti-egg IgE (P < 0Æ001,
c2 = 1 5Æ41, df = 1), IgG2 (P = 0Æ012, c2 = 6Æ52, df = 1)
and IgG4 (P = 0Æ012, c2 = 6Æ52, df = 1). The presence of
malaria parasites in the blood stream did not have a
significant effect on the number of people with detect-
able plasma cytokine or antibody levels (analysis not
shown).
Of the 227 participants, all but one person had at least
one detectable cytokine. This individual was 11 years old
and was negative for both schistosome eggs and malaria
parasites. The least frequently detected cytokines were IL-
17, IL-5 and IFN-c, while the most frequently detected
cytokines were IL-13, IL-4 and IL-21 (Table 2). Egg-posi-
tive people had more IL-2 and IL-23 producers compared
to egg-negative people, although IL-23 positive people
mostly carried light infections. More egg-negative people
produced IL-10 compared to egg-positive people as shown
in Figure 2.
Cytokine levels differ between hosts of different age
Levels of some cytokines varied with host age, the most
pronounced changes occurring in IL-4 and IL-10 levels,
which showed a significant overall increase with age
(F = 21Æ9, df = 144Æ1, P < 0Æ0001 and F = 4Æ8, df = 144,1,
P = 0Æ031, respectively). Further analyses of the cytokine
age profiles partitioned by infection status indicated that
Table 1 Number of people with detectable antibody levels directed against adult worm (anti-SWAP), cercariae (anti-CAP) and egg (anti-
SEA)-soluble antigens partitioned by schistosome infection status
S. haematobium S. haematobium
Negative Positive
Number with Sample % with Number with Sample % with
Detectable levels Size Detectable levels Detectable levels Size Detectable levels
Anti-SWAP antibodies
IgA 94 101 93 121 126 95
IgE 56 98 57 72 125 57
IgM 101 101 100 126 126 100
IgG1 89 101 88 123 126 93
IgG2 74 101 73 104 126 78
IgG3 77 101 76 112 126 83
IgG4 84 101 83 112 126 86
Anti-CAP antibodies
IgA 97 101 96 123 126 98
IgE 84 101 83 116 126 92
IgM 101 101 100 126 126 100
IgG1 101 101 100 126 126 100
IgG2 100 101 99 124 126 98
IgG3 90 101 89 118 126 94
IgG4 83 101 82 117 126 93
Anti-SEA antibodies
IgA 100 101 99 124 126 98
IgE 48 101 48 92 126 73
IgM 101 101 100 126 126 100
IgG1 99 101 98 126 126 100
IgG2 92 101 91 124 126 98
IgG3 97 101 96 124 126 98
IgG4 92 101 91 124 126 98
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Table 2 Number of people with detectable cytokine levels antigens divided by schistosome infection status. For each cytokine the number
of people with detectable levels was compared between egg-negative and egg-positive people by a chi-squared (c2) test. Significant
differences are denoted in bold
Cytokine
S. haematobium negative S. haematobium positive Statistics
Number
with
detectable
levels
Sample
size
% with
detectable
cytokine
levels
Number
with
detectable
levels
Sample
size
% with
detectable
cytokine
levels
Egg+ve vs.
egg)ve c2 value,
P-value
IFN-gamma 28 101 28 41 126 33 0Æ62, P = 0Æ26
IL-2 38 96 40 62 116 53 4Æ05, P = 0Æ03
IL-4 88 101 87 99 126 79 2Æ88, P = 0Æ065
IL-5 35 101 35 34 126 27 1Æ56, P = 0Æ133
IL-10 68 101 67 52 126 41 15Æ28, P < 0Æ001
IL-13 98 101 97 115 126 91 3Æ21, P = 0Æ062
IL-17 8 101 8 10 126 8 0, P = 0Æ6
IL-21 70 96 73 96 116 83 3, P = 0Æ06
IL-23 18 96 19 39 116 34 5Æ91, P = 0Æ011
P = 0·03
P < 0·001
P = 0·011
73/101
26/96116/12693/101
11/1263/10174/12633/10192/12666/101
27/12613/10154/11658/9685/126
20/116 77/11678/96
Figure 2 Systemic cytokine levels in the population partitioned by schistosome infection status. Bars represent the result of a chi-squared
test comparing the number of people with detectable cytokine levels between schistosome egg-negative and egg-positive people. Figures
represent the number of people in whom the cytokine was not detected out of the total number assayed who are either schistosome negative
or positive.
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there was large variation within cytokine levels between
different age groups and consequently significant patterns
could not be detected across the age range. However, Fig-
ure 3a shows that age-related changes in cytokine produc-
tion partitioned by schistosome infection status were most
pronounced for IL-4, IL-5, and IL-10. IL-5 levels declined
with age in egg-positive people while IL-10 levels tended
to increase. In egg-negative people IL-10 levels followed
the age-infection profile while IL-5 levels lagged behind,
only beginning to rise when infection levels peaked. IL-2,
IL-13, IL-17, IL-21 and IL-23 showed little variation with
host age in both egg-negative and egg-positive people.
IFN-c levels peaked early in egg-negative people but did
not show a distinct peak in egg-positive people.
Cytokine levels differ with schistosome infection intensity
Plots of infection intensity vs. cytokine levels indicated
that most cytokines had a dichotomous relationship with
infection intensity, so that high egg counts were associated
with low cytokine levels. Notable exceptions were IL-4 and
IL-2 as shown in Figure 3b, where there were some high
cytokine levels associated with high egg counts. The 18
people with detectable IL-17 levels as well as the majority
of IL-23 producers all carried little or no infection (none
with more than 75 eggs ⁄ 10 mL urine in the case of IL-17
producers). These relationships were not formally tested at
this stage because of the dichotomous nature of the data
but were included in the parametric tests determining the
a)
Figure 3 Age and infection intensity profiles of the cytokines. a) Relationship between cytokine levels and age-associated plasma cytokine
levels partitioned by the participant’s schistosome infection status (egg-positive vs. egg-negative) showing clear and distinct patterns for
IL-4, IL-5 and IL-10. Squares = schistosome egg positive, diamonds = schistosome egg negative. b) Relationship between S. haematobium
infection intensity for individual participants and their levels of plasma cytokines.
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effect of systemic immune responses on schistosome infec-
tion intensity described later.
Cytokine levels show correlations with each other
Levels of circulating cytokines were related to each other,
with all the statistically significant associations being posi-
tive as shown in Table 3. IL-2 and IL-10 showed the most
numerous significant associations with the other cytokines,
while IL-21 showed the least association with any of the
other cytokines measured (being related only to IL-2 and
IL-23). Levels of IFN-c (Th1 response marker), IL-4 ⁄ IL-5
(Th2 response markers) and IL-17 (marker of Th17
responses) showed positive correlations with IL-10. IL-4
and IL-5 levels were significantly correlated despite the
differences in the age profiles of their levels in egg-negative
compared to egg-positive people described earlier. Similar
to IL-23 levels, plasma levels of IL-4 and IL-5 were corre-
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Figure 3 Continued.
Table 3 Cytokine correlations. Nonparametric Spearman’s correlation between cytokines, giving the r coefficient and the P-value in
brackets. Significant P-values are highlighted in bold while P-values still significant after Bonferoni correction (52) are indicated by shaded
cells
IL-4 IL-5 IL-10 IL-13 IL-17 IL-21 IL-23 IFN-c
IL-2 )0Æ08 (0Æ11) )0Æ08 (0Æ11) 0Æ01 (0Æ46) 0Æ17 (P = 0Æ006) )0Æ08 (0Æ11) 0Æ55 (P < 0Æ0001) 0Æ56 (P < 0Æ0001) 0Æ14 (P = 0Æ024)
IL-4 0Æ6 (P < 0Æ0001) 0Æ6 (P < 0Æ0001) )0Æ08 (0Æ11) 0Æ6 (P < 0Æ0001) )0Æ08 (0Æ11) 0Æ001 (0Æ49) )0Æ05 (0Æ22)
IL-5 0Æ6 (P < 0Æ0001) )0Æ1 (0Æ07) 0Æ13 (P = 0Æ022) )0Æ1 (0Æ08) )0Æ033 (0Æ32) 0Æ003 (0Æ48)
IL-10 )0Æ022 (0Æ37) 0Æ6 (P < 0Æ0001) )0Æ08 (0Æ11) 0Æ1 (0Æ08) 0Æ46 (P = 0Æ007)
IL-13 0Æ8 (0Æ11) 0Æ05 (0Æ25) 0Æ06 (0Æ2) 0Æ11 (0Æ053)
IL-17 0Æ06 (0Æ2) 0Æ12 (P = 0Æ037) 0Æ01 (0Æ06)
IL-21 0Æ6 (P < 0Æ0001) 0Æ06 (0Æ2)
IL-23 0Æ17 (P = 0Æ008)
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lated to those of IL-17. The large number of significantly
correlated cytokines measured in the study suggested
potential underlying biological relationships. These rela-
tionships were captured in fewer variables (principal com-
ponents), which were subsequently used to determine the
effect of the potential underlying biological relationships
on schistosome infection intensity.
Antibody and cytokine responses cluster into different
immunological groups
The factor analysis reduced the 30 immunology variables
into five main principal components (PCA) 1-5 described
in Table 4. The PCA 1 is strongly influenced by the schis-
tosome-specific antibody responses reflecting exposure and
acquired immunity to the parasites. PCA 2 was made up
of the cytokines IL-4 and IL-5 (Th2 cytokines) as well as
some antibodies (anti-cercariae ⁄ IgM and IgG2 and anti-
egg IgM previously associated with both exposure to and
protection against infection) (35,36). PCA 3 was strongly
influenced by levels of IL-10 and the antibodies anti-egg
IgG1 and anti-adult worm IgE and IgA all of which have
been associated with effector immune responses against
the parasite (25,37–39). The two closely related cytokines
IL-17 and IL-23 had the strongest loadings onto PCA 4,
while IFN-c and IL-2 had the strongest loading on PCA 5.
Thus, the different principal components were taken to
indicate different underlying biological process with PCA1
indicating exposure to the parasite and PCA 2-4 indicating
different effector responses whose relationships to schisto-
some infection status were subsequently investigated.
Plasma cytokine and antibody responses vary with schis-
tosome infection status
The effects of the principal components on schistosome
infection status were determined after allowing for the
effects of participant sex, residential village and age. This
analysis showed that infection status was significantly
associated with PCA1 (schistosome-specific antibody
responses), PCA 3 (IL-10, anti-worm IgA, IgE and anti-
egg IgG1) and PCA 5 (INF-c and IL-2). In addition, the
effects of PCA-5 on infection status were modified by
PCA2 (IL-4, IL-5, CAP IgM and IgG2). PCA 4 (IL-17
and IL-23) did not have a significant effect on infection
status shown in Table 5. As the study aimed to determine
the effects of infection history on the systemic antibody
and cytokines levels, PCA values in egg-negative people in
the youngest age group (those with little or no experience
of infection) were compared to those in the oldest age
group (lifelong residence with little or no infection despite
regular contact with infective water, putatively because of
the development of acquired immunity). This analysis
showed that levels of PCA 1 (antibodies) and PCA 2 (IL-
4, IL-5, CAP IgM and IgG2) were significantly higher in
older egg-negative people than in younger egg-negative
people (Figure 4). There were no significant differences
amongst the other PCAs. The analysis also showed some
interesting though not significant differences between the
youngest and oldest egg-positive people where levels of
both PCA 2 and PCA 3 were higher in the oldest com-
pared to the youngest age group (Figure 4).
Table 4 Principal components which are linear transformation of
the large number of highly correlated antibody and cytokine
variables into a smaller number of uncorrelated variables. The
components (PCA1-5) are extracted according to the amount of
variation in the data they explain so the first component explains
the most variation and each subsequent component is included if
it explains a significant amount of variation present with the
data. The loading value of each individual cytokine or antibody
indicates the correlation between the extracted component and
the original variable so that variables with strong loadings (>5 or
<)5) are indicated in bold
Immune
variables
measured PCA1 PCA2 PCA3 PCA4 PCA5
% variation
explained
28% 12% 10% 6% 6%
INF-y 0Æ11 )0Æ2 0Æ23 )0Æ08 0Æ59
IL-2 0Æ15 0Æ02 )0Æ05 0Æ1 0Æ56
IL-4 0Æ09 0Æ69 0Æ42 0Æ02 )0Æ01
IL-5 )0Æ01 0Æ82 0Æ04 0Æ08 )0Æ04
IL-10 0Æ01 0Æ38 0Æ55 )0Æ04 0Æ28
IL-13 )0Æ07 )0Æ01 )0Æ1 0 0Æ47
IL-17 0Æ08 0Æ17 0Æ21 0Æ58 0Æ08
IL-21 0Æ14 )0Æ16 0Æ1 0Æ41 0Æ33
IL-23 0Æ22 )0Æ09 0Æ24 0Æ7 0Æ27
CAP IgA 0Æ7 )0Æ1 0Æ37 )0Æ21 )0Æ12
CAP IgG1 0Æ63 0Æ35 )0Æ34 )0Æ01 0Æ19
CAP IgG2 0Æ4 )0Æ5 )0Æ22 0Æ27 )0Æ05
CAP IgG3 0Æ49 )0Æ42 )0Æ22 )0Æ23 0Æ25
CAP IgG4 0Æ69 )0Æ03 )0Æ23 0Æ32 )0Æ16
CAP IgE 0Æ68 )0Æ3 0Æ13 )0Æ24 )0Æ13
CAP IgM 0Æ69 0Æ53 0Æ02 )0Æ08 0Æ05
SEA IgA 0Æ73 )0Æ07 0Æ3 )0Æ17 )0Æ17
SEA IgG1 0Æ64 0Æ26 )0Æ54 )0Æ07 0Æ19
SEA IgG2 0Æ59 )0Æ47 )0Æ44 0Æ14 )0Æ1
SEA IgG3 0Æ45 )0Æ44 )0Æ21 )0Æ31 0Æ38
SEA IgG4 0Æ68 0Æ14 )0Æ4 0Æ09 )0Æ08
SEA IgE 0Æ57 0Æ13 0Æ05 )0Æ32 )0Æ17
SEA IgM 0Æ65 0Æ58 )0Æ14 )0Æ14 0Æ15
SWAP IgA 0Æ54 )0Æ23 0Æ64 0Æ08 )0Æ05
SWAP IgG1 0Æ64 0Æ33 )0Æ41 0Æ13 )0Æ04
SWAP IgG2 0Æ57 )0Æ21 0Æ27 0Æ4 )0Æ24
SWAP IgG3 0Æ69 )0Æ25 0Æ24 )0Æ1 0Æ02
SWAP IgG4 0Æ62 0Æ17 )0Æ21 0Æ3 )0Æ24
SWAP IgE 0Æ55 )0Æ25 0Æ62 )0Æ05 )0Æ04
SWAP IgM 0Æ74 0Æ21 0Æ34 )0Æ15 0Æ13
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DISCUSSION
This study focused on systemic cytokine and antibody
responses in Zimbabweans exposed to S. haematobium
infection to determine the relationship between host
immune responses and schistosome infection status. Sev-
eral experimental and human studies investigating schisto-
some-specific responses have described the presence of
schistosome-specific Th2 responses (40).This study investi-
gated whether these parasite-specific responses were
reflected in the systemic environment, representing both
broader immune activation to pathogen and environmental
challenges, and immunological cross-talk which may
down-regulate particular components.
Not surprisingly, all participants had detectable levels of
parasite-specific antibodies particularly IgM reflecting that
they had been exposed to schistosome infection. Similarly,
all participants except one egg-negative child had detect-
able levels of at least one cytokine. The systemic environ-
ment in schistosome egg-positive participants differed
from that in egg-negative participants, and differed
between young and old egg-negative people (i.e. those with
a short vs. long history of exposure to schistosome infec-
tions).
Systemic cytokines are produced in response to different
antigens arising from various exogenous sources but
despite the potentially large number of cytokine-inducing
agents, there was a significant relationship between circu-
lating cytokines and schistosome infection status. Signifi-
cantly more schistosome egg-negative individuals had
detectable levels of IL-10 than egg-positive people,
whereas a significantly larger number of egg-positive peo-
ple had detectable IL-2 and IL-23 levels. While the role of
IL-23 in human schistosomiasis remains to be established,
its more frequent occurrence in egg-positive participants is
consistent with its postulated role in immunopathology
suggested by murine studies (41). In murine schistosomia-
sis (41), IL-23 and IL-17 are associated with the develop-
ment of pathology. In this study, the two cytokines were
positively correlated, but the 18 people with detectable
IL-17 were mostly egg-negative or people excreting low
levels of schistosome eggs (people who are less likely to
have egg-induced immunopathology), the most heavily
infected people (people who would be expected to have
egg-induced immunopathology) did not have detectable
levels of IL-17. The two cytokines IL-13 and IL-4 were
produced by a large number of the study participants, but
they showed no relationship to schistosome infection sta-
tus either alone or in the PCA analysis. They may have
been stimulated in response to other exogenous agents
such as other pathogens (e.g. HIV (42) which is prevalent
in Zimbabwe) and allergens (43) (e.g. house dust mites)
not investigated in this study.
Interestingly, despite the overall significant positive cor-
relation between IL-4 and IL-5 levels, the age profiles of
the two cytokines differed. IL-4 levels increased with age
across the population but, in contrast, IL-5 levels
increased with age only in egg-negative people but
declined with age in egg-positive people. This suggests
that there may be temporal differences in the production
of the two cytokines with respect to antigen exposure.
Field studies in schistosomiasis (9,12) and filariasis (44)
as well as mechanistic experimental studies (45) have
reported dissociation in IL-4 and IL-5 production and
effector functions. Overall, the systemic levels of IL-4,
IL-5, IL-10 and IFN-c showed similar patterns with age
to those previously reported for the parasite-specific cyto-
kines in this population (46), indicating that schistosome-
specific cytokine responses are associated with systemic
cytokine levels.
The study clearly demonstrated that the systemic anti-
body and cytokine levels clustered into different groups,
Table 5 Relationship between systemic immune responses
(antibody and cytokine) and S. haematobium infection status. The
test statistics were obtained using sequential sums of squares
which tested for each variable after allowing for all the variables
preceding it in the model. The variables were tested in the order
in which they are presented in the table, after allowing for
participant sex, village of residency and age group. Schistosome
infection status was denoted as negative for people with zero egg
counts for all urine samples presented or positive for people with
at least one egg detected in one of their urine samples was the
dependent variable. Significant variables are shown in bold.
Source of variation df
Mean
square F P-value
PCA1(antibody
responses)
1 3Æ64 19Æ29 0Æ00
PCA2(IL-4, IL_5,
CAP IgM, IgG2)
1 0Æ33 1Æ73 0Æ19
PCA3(IL-10, -SEA
IgG1, SWAP IgA,
SWAP IgE)
1 4Æ50 23Æ85 0Æ00
PCA4(IL-17, IL-23) 1 0Æ12 0Æ61 0Æ43
PCA5(IFN-y, IL-2) 1 1Æ09 5Æ79 0Æ02
PCA1*PCA2 1 0Æ69 3Æ64 0Æ06
PCA1*PCA3 1 0Æ06 0Æ33 0Æ57
PCA1*PCA4 1 0Æ47 2Æ47 0Æ12
PCA1*PCA5 1 0Æ06 0Æ30 0Æ58
PCA2*PCA3 1 0Æ10 0Æ53 0Æ47
PCA2*PCA4 1 0Æ00 0Æ00 0Æ95
PCA2*PCA5 1 0Æ89 4Æ72 0Æ03
PCA3*PCA4 1 0Æ22 1Æ15 0Æ28
PCA3*PCA5 1 0Æ15 0Æ77 0Æ38
PCA4*PCA5 1 0Æ00 0Æ00 0Æ95
Total 191
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reflecting exposure to parasite antigens as well as different
effector-related responses. Parasite-specific antibody res-
ponses mostly clustered together and were higher in egg-
negative people compared with egg-positive people. These
antibody responses would represent both responses indi-
cating exposure to infection as well as responses associated
with protection to infection ⁄ re-infection. The Th2-like
cytokines together with anti-cercariae IgM and IgG2 were
also higher in egg-negative people, but their association
with infection status was modified by the levels of IFN-c
and IL-2 consistent with Th1 ⁄Th2 cross-regulation of
immune responses (47). IL-10 and the antibodies IgG1,
IgA and IgG4 were significantly higher in egg-negative
than egg-positive people. Comparison of systemic levels of
antibodies and cytokines in the youngest and oldest egg-
negative participants allowed the effect of differences in
history of exposure to parasites antigens to be determined.
The use of age as a proxy for exposure history is possible
in this population because all participants were lifelong
residents of the area with frequent contact with infective
water and had never received anti-helminthic treatment.
This analysis showed a clear difference in levels of
parasite-specific antibodies and levels of the Th2 cytokines
(IL-4 and IL-5), both of which were significantly higher in
older egg-negative people suggesting that these were asso-
ciated with resistance to infection ⁄ re-infection.
This study indicates that S. haematobium infection is
associated with a Th2-systemic response, but that this
response differs between people carrying a patent infection
(positive egg counts) and putatively resistant individuals
(egg-negative lifelong residents with continued exposure to
infective water) who have experienced previous infection
(as evidenced by the presence of schistosome-specific IgA,
IgG and IgE antibodies). Egg-positive people have a mod-
ified Th2 systemic environment composed of parasite-spe-
cific antibodies and IL-4 which is modulated by IFN-c
and IL-2, and levels of the potentially protective IL-5
decline over time. They also have a more prevalent IL-21
and IL-23 response than egg-negative people, suggesting
that either or both Th1 or Th17 cells are counteracting
the development of a strong Th2 response. In addition,
IL-2 is a key cytokine for the maintenance of regulatory T
cells (48), which may show heightened activity in patent
infection (49). Older egg-negative people have a fully Th2-
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Figure 4 Relationship between systemic environment and schistosome infection status for the different participants divided by age group.
Arbitrary values (X-axis) represent mean values of the principal components PCA1-5. Bars represent different age groups; open = 5–
10 years old, solid = 11–12 years old and hashed 13+ years old. Statistical comparisons are made between egg-negative young people 5–
10 years old (open bars) and old 13+ years old egg-negative people (hashed bars).
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dominated cytokine environment comprising of IL-4, IL-5,
IL-10 and parasite-specific antibodies. It is particularly
interesting that IL-10 is indicated to be primarily a pro-
Th2 factor, rather than playing an immunosuppressive
role. Analysis of the peripheral blood mononuclear cells
from the population will allow us to determine whether in
human schistosomiasis, as recently reported in filariasis,
the majority of IL-10 production derives from CD25-nega-
tive Th2-like cells, rather than the regulatory T cell subset
(50).
In conclusion, the systemic cytokine environment in
schistosome exposed ⁄ infected people does reflect the infec-
tion status of the host, and varies significantly with age
i.e. history of exposure to infection. Furthermore, a mixed
Th1 ⁄Th2 systemic environment occurs in people with pat-
ent schistosome infection, while a stronger Th2-dominated
suite of cytokines is evident in egg-negative individuals.
Future studies integrating our understanding of both total
and antigen-specific cytokine production will help to fur-
ther identify the key components of anti-parasite immu-
nity and to develop possible mechanistic explanations for
the helminth-associated immunomodulation of responses
to third party antigens (51).
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